O Abramsky - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

O Abramsky

Showing results (231-240 of 240) with videos related to

Pageof 24

Sort By:

You have reached the last page of results.This site can display upto 240 results.

Multiple Sclerosis (Houndmills, Basingstoke, England)|September 14, 2010

Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled studyG Comi, O Abramsky, T Arbizu, et al.

Journal of the Neurological Sciences|January 1, 1979

Antibodies to galactocerebroside bind to oligodendroglia in suspension cultureR P Lisak, O Abramsky, S H Dorfman, et al.

Developmental Neuroscience|January 1, 1992

Endogenous and exogenous alpha-fetoproteins as differential markers of cultured neonatal mouse Schwann cells and fibroblastsJ Trojan, J M Boutry, J J Hauw, et al.

Multiple Sclerosis (Houndmills, Basingstoke, England)|January 5, 2000

Evidence for the genetic role of human leukocyte antigens in low frequency DRB1*1501 multiple sclerosis patients in IsraelA Karni, Y Kohn, C Safirman, et al.

The New England Journal of Medicine|April 18, 1991

Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob diseaseK Hsiao, Z Meiner, E Kahana, et al.

Annals of Neurology|November 1, 1993

Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomideD M Karussis, D Lehmann, S Slavin, et al.

Lancet (London, England)|June 24, 2008

Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb studyG Comi, A Pulizzi, M Rovaris, et al.

European Journal of Immunology|December 12, 1997

Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regionsN Kerlero de Rosbo, M Hoffman, I Mendel, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 30, 1996

Peptide analogs to pathogenic epitopes of the human acetylcholine receptor alpha subunit as potential modulators of myasthenia gravisE Zisman, Y Katz-Levy, M Dayan, et al.

Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2005

Randomized study of once-weekly interferon beta-1la therapy in relapsing multiple sclerosis: three-year data from the OWIMS studyM S Freedman, G S Francis, E A C M Sanders, et al.

Pageof 24

Search research articles

Showing results (231-240 of 240) with videos related to

Sort By:

Pageof 24

You have reached the last page of results.This site can display upto 240 results.

Multiple Sclerosis (Houndmills, Basingstoke, England)|September 14, 2010

Journal of the Neurological Sciences|January 1, 1979

Antibodies to galactocerebroside bind to oligodendroglia in suspension cultureR P Lisak, O Abramsky, S H Dorfman, et al.

Developmental Neuroscience|January 1, 1992

Endogenous and exogenous alpha-fetoproteins as differential markers of cultured neonatal mouse Schwann cells and fibroblastsJ Trojan, J M Boutry, J J Hauw, et al.

Multiple Sclerosis (Houndmills, Basingstoke, England)|January 5, 2000

Evidence for the genetic role of human leukocyte antigens in low frequency DRB1*1501 multiple sclerosis patients in IsraelA Karni, Y Kohn, C Safirman, et al.

The New England Journal of Medicine|April 18, 1991

Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob diseaseK Hsiao, Z Meiner, E Kahana, et al.

Annals of Neurology|November 1, 1993

Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomideD M Karussis, D Lehmann, S Slavin, et al.

Lancet (London, England)|June 24, 2008

European Journal of Immunology|December 12, 1997

Proceedings of the National Academy of Sciences of the United States of America|April 30, 1996

Peptide analogs to pathogenic epitopes of the human acetylcholine receptor alpha subunit as potential modulators of myasthenia gravisE Zisman, Y Katz-Levy, M Dayan, et al.

Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2005

Randomized study of once-weekly interferon beta-1la therapy in relapsing multiple sclerosis: three-year data from the OWIMS studyM S Freedman, G S Francis, E A C M Sanders, et al.

Pageof 24